5/22/2015 12:40:40 PM -

Reported earnings +7% on +72% sales revenues for the Mar '15 quarter. Holding its ground in a tight range since gapping up on 3/05/15 on news AbbVie Inc (ABBV) will buy the leukemia drugmaker for $21 Billion. Held its ground stubbornly after a streak of gains on ever-increasing volume. Prior mid-day reports cautioned members - "Reported strong Sep and Dec '14 earnings but fundamental concerns remain. Quarterly and annual earnings history (C and A criteria) has not been strong and steady."


3/9/2015 12:45:57 PM -

Gapped up on 3/05/15 for another new 52-week high on news AbbVie Inc (ABBV) will buy the leukemia drugmaker for $21 Billion. Held its ground stubbornly after a streak of gains on ever-increasing volume. Prior mid-day reports cautioned members - "Reported strong Sep and Dec '14 earnings but fundamental concerns remain. Quarterly and annual earnings history (C and A criteria) has not been strong and steady."


3/6/2015 12:37:32 PM -

Gapped up on 3/05/15 for another new 52-week high on news AbbVie Inc (ABBV) will buy the leukemia drugmaker for $21 Billion. Held its ground stubbornly after a streak of gains on ever-increasing volume. Prior mid-day reports cautioned members - "Reported strong Sep and Dec '14 earnings but fundamental concerns remain. Quarterly and annual earnings history (C and A criteria) has not been strong and steady."


3/5/2015 1:20:24 PM -

Gapped up today for another new 52-week high on news AbbVie Inc (ABBV) will buy the leukemia drugmaker for $21 Billion. Held its ground stubbornly after a streak of gains on ever-increasing volume. Prior mid-day reports cautioned members - "Reported strong Sep and Dec '14 earnings but fundamental concerns remain. Quarterly and annual earnings history (C and A criteria) has not been strong and steady."


3/4/2015 12:47:37 PM -

Holding its ground after powering to new 52-week highs with a streak of gains on ever-increasing volume. The 2/26/15 mid-day report cautioned members - "Reported strong Sep and Dec '14 earnings but fundamental concerns remain. Quarterly and annual earnings history (C and A criteria) has not been strong and steady."


2/26/2015 12:41:21 PM -

Powered to a new 52-week high with a streak of gains on ever-increasing volume. Reported strong Sep and Dec '14 earnings but fundamental concerns remain. Prior mid-day reports cautioned members - "Quarterly and annual earnings history (C and A criteria) has not been strong and steady."


2/19/2015 1:10:40 PM -

Hitting a new 52-week high with today's 5th consecutive gain on ever-increasing volume. Prior mid-day reports cautioned members - "Quarterly and annual earnings history (C and A criteria) has not been strong and steady."


2/3/2015 1:20:11 PM -

Pulling back after recently wedging to new 52-week highs. Prior mid-day reports cautioned members - "Quarterly and annual earnings history (C and A criteria) has not been strong and steady."


1/27/2015 12:37:00 PM -

Making steady progress since a gap up on 1/13/15, and it is hitting another new 52-week high with today's 4th consecutive gain. Prior mid-day reports cautioned members - "Quarterly and annual earnings history (C and A criteria) has not been strong and steady."


1/21/2015 12:41:57 PM -

Gapped up on 1/13/15 and it is hitting another new 52-week high with today's 4th consecutive gain. Prior mid-day reports cautioned members - "Quarterly and annual earnings history (C and A criteria) has not been strong and steady."


1/14/2015 12:33:02 PM -

Gapped up on the prior session clearing a prior high and challenging its 52-week high. The 1/13//15 mid-day report cautioned members - "Quarterly and annual earnings history (C and A criteria) has not been strong and steady."


1/13/2015 12:25:13 PM - Gapped up today clearing a prior high and challenging its 52-week high. Quarterly and annual earnings history (C and A criteria) has not been strong and steady.